masoprocol has been researched along with Invasiveness, Neoplasm in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, X; Chen, G; Cui, W; Cui, Y; Gu, A; Li, T; Xu, C; Yang, X; Yu, S; Zhang, X | 1 |
| Bian, XW; Cui, W; Cui, YH; Dang, WQ; Kung, HF; Ma, LN; Ping, YF; Qian, C; Shi, Y; Wang, B; Wang, QL; Wang, Z; Xiao, HL; Xu, C; Xu, SL; Yang, L; Yu, SC; Zhang, X | 1 |
| Chen, Q; Du, X; Jin, R; Li, W; Li, X; Liang, G; Qiu, P; Shen, L; Wang, F; Wu, J; Xia, Y; Xu, C; Zhao, Y | 1 |
| Boonstra, J; de Ruiter, N; Joling, P; Rijksen, G; Van Bergen en Henegouwen, PM; van den Tweel, JG; van der Heyden, MA; Verdaasdonk, MA | 1 |
4 other study(ies) available for masoprocol and Invasiveness, Neoplasm
| Article | Year |
|---|---|
A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Glioma; Glycoproteins; Humans; Masoprocol; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Peptides; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays; Zebrafish | 2014 |
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; RNA Interference; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinase-2; Transplantation, Heterologous | 2015 |
The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Humans; Masoprocol; Neoplasm Invasiveness; Phosphorylation; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stomach Neoplasms | 2015 |
The actin binding domain of the epidermal growth factor receptor is required for EGF-stimulated tissue invasion.
Topics: 3T3 Cells; Actins; Androstadienes; Animals; Binding Sites; Bone Marrow Cells; Cell Adhesion; Cell Movement; Cells, Cultured; Coculture Techniques; Cytoskeleton; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Lipoxygenase Inhibitors; Masoprocol; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Signal Transduction; Wortmannin | 1997 |